Clinical Cancer Research Joint Metastasis Research Society-AACR Conference on Metastasis Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hashimoto, Y.
Right arrow Articles by Shimada, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hashimoto, Y.
Right arrow Articles by Shimada, Y.
Clinical Cancer Research Vol. 11, 2597-2605, April 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Prognostic Significance of Fascin Overexpression in Human Esophageal Squamous Cell Carcinoma

Yosuke Hashimoto1, Tetsuo Ito1, Harutaka Inoue1, Tomoyuki Okumura1, Eiji Tanaka1, Shigeru Tsunoda1, Motoshige Higashiyama1, Go Watanabe1, Masayuki Imamura2 and Yutaka Shimada1

Authors' Affiliations: 1 Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan and
2 Department of Surgery, Saiseikai Noe Hospital, Osaka, Japan

Requests for reprints: Yutaka Shimada, Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawara-Cho, Sakyo-Ku, Kyoto 606-8507, Japan. Phone: 81-75-751-3445; Fax: 81-75-751-3219; E-mail: shimada{at}kuhp.kyoto-u.ac.jp.

Purpose: Fascin, an actin bundling protein, induces membrane protrusions and increased cell motility in various transformed cells. The expression of fascin in epithelial neoplasms has been described only recently, and the role of fascin in esophageal squamous cell carcinoma (ESCC) is still unknown.

Experimental Design: Paraffin sections of 200 patients with ESCC were immunohistochemically investigated. The expression levels of fascin mRNA in 20 ESCC tissues were compared with that in corresponding normal esophageal epithelium by semiquantitative reverse transcription-PCR. We also examined fascin protein expression in 33 ESCC cell lines. The role of fascin in cell motility and invasiveness in ESCC cells was assessed by the vector-based small interfering RNA.

Results: In immunohistochemical study, the intensity of fascin expression was usually increased in the tumor compared with that in normal epithelium. Fascin overexpression was significantly associated with a poor prognosis (immunoreactive rate, P = 0.033; immunoreactive intensity, P = 0.031). The fascin immunoreactive rate was associated with extent of the tumor (P = 0.002) and lymph node metastasis (P = 0.003). Multivariate analysis showed that fascin expression intensity was an independent prognostic factor, but the immunoreactive rate was not.

In addition, up-regulation of fascin mRNA was found in 60% (12 of 20) of patients. In vitro study revealed that all 33 ESCC cell lines expressed fascin protein at a certain level. KYSE170, one of the fascin-overexpressed cells, decreased its motile and invasive properties after down-regulation of fascin expression.

Conclusion: Our findings suggest that fascin overexpression may play an important role in the progression of ESCC.

Key Words: Lymph node metastasis • tumor invasion • vector-based siRNA




This article has been cited by other articles:


Home page
Cancer Res.Home page
T. Ito, Y. Shimada, T. Kan, S. David, Y. Cheng, Y. Mori, R. Agarwal, B. Paun, Z. Jin, A. Olaru, et al.
Pituitary Tumor-Transforming 1 Increases Cell Motility and Promotes Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma
Cancer Res., May 1, 2008; 68(9): 3214 - 3224.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Y. Hashimoto, M. Parsons, and J. C. Adams
Dual Actin-bundling and Protein Kinase C-binding Activities of Fascin Regulate Carcinoma Cell Migration Downstream of Rac and Contribute to Metastasis
Mol. Biol. Cell, November 1, 2007; 18(11): 4591 - 4602.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Sugito, H. Ishiguro, Y. Kuwabara, M. Kimura, A. Mitsui, H. Kurehara, T. Ando, R. Mori, N. Takashima, R. Ogawa, et al.
RNASEN Regulates Cell Proliferation and Affects Survival in Esophageal Cancer Patients
Clin. Cancer Res., December 15, 2006; 12(24): 7322 - 7328.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. J. Choi, D. K. Yang, C. H. Son, K. E. Lee, J. I. Lee, and M. S. Roh
Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3cm or less in diameter.
Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 538 - 542.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
H Zhang, L Xu, D Xiao, J Xie, H Zeng, W Cai, Y Niu, Z Yang, Z Shen, and E Li
Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma
J. Clin. Pathol., September 1, 2006; 59(9): 958 - 964.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. M. Rodriguez-Pinilla, D. Sarrio, E. Honrado, D. Hardisson, F. Calero, J. Benitez, and J. Palacios
Prognostic Significance of Basal-Like Phenotype and Fascin Expression in Node-Negative Invasive Breast Carcinomas
Clin. Cancer Res., March 1, 2006; 12(5): 1533 - 1539.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Ito, Y. Hashimoto, E. Tanaka, T. Kan, S. Tsunoda, F. Sato, M. Higashiyama, T. Okumura, and Y. Shimada
An Inducible Short-Hairpin RNA Vector against Osteopontin Reduces Metastatic Potential of Human Esophageal Squamous Cell Carcinoma In vitro and In vivo
Clin. Cancer Res., February 15, 2006; 12(4): 1308 - 1316.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.